Cluster Headache Therapy
Reports from Thomas Jefferson University, Department of Neurology add new data to research in cluster headache therapy
Published in Medical Letter on the CDC and FDA, May 2nd, 2010
Fresh data on cluster headache are presented in the report 'Valproate semisodium ER for migraine and cluster headache prophylaxis.' According to recent research from the United States, "IMPORTANCE OF THE FIELD: Migraine and cluster headache (CH) are disabling syndromes that often require prophylactic treatment. Valproate semisodium ER (VPS ER) is FDA-approved for the treatment of epilepsy, acute mania in bipolar disorder and migraine prophylaxis."
"AREAS COVERED IN THIS REVIEW: We reviewed literature regarding VPS ER pharmacokinetics and its use in migraine and CH prophylaxis. WHAT THE READER WILL GAIN: VPS ER is well studied and effective in the preventive treatment of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Buck Institute for Age Research
Antidepressants as treatment immediately following a stroke? - Aeolus Pharmaceuticals, Inc.
Aeolus Pharmaceuticals Announces the Initiation of a Second Study of AEOL 10150 as a Medical Countermeasure for GI Acute Radiation Syndrome Funded by the National Institutes of Health's National Institute for Allergy and Infectious Diseases - American Academy of Dermatology
New Study Evaluates Effectiveness of Vitamins for the Treatment of Sun-Damaged Skin - biospace med
Clinical study demonstrates EOS reduces patient's radiation exposure by up to 89% compared to standard CR x-rays while substantially improving image quality - Cargill Incorporated
Cargill's Steviol Glycosides Dossier Receives - Inter Canadian Business Service
Dr. Jeffrey Olson MD to head up Canadian Bio Med Systems Inc., as new Chairman - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
